181 related articles for article (PubMed ID: 25616277)
1. Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses.
Hu T; Li YS; Chen B; Chang YF; Liu GC; Hong Y; Chen HL; Xiyang YB
Exp Biol Med (Maywood); 2015 Oct; 240(10):1287-97. PubMed ID: 25616277
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation.
Meng Q; Zhang Y; Sun H; Yang X; Hao S; Liu B; Zhou H; Wang Y; Xu ZX
Redox Biol; 2024 May; 71():103108. PubMed ID: 38457903
[TBL] [Abstract][Full Text] [Related]
3. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
4. miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD.
Hu T; Chang YF; Xiao Z; Mao R; Tong J; Chen B; Liu GC; Hong Y; Chen HL; Kong SY; Huang YM; Xiyang YB; Jin H
Oncotarget; 2016 Dec; 7(52):86103-86116. PubMed ID: 27861141
[TBL] [Abstract][Full Text] [Related]
5. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells].
Wei XM; Wang Q; Gao SJ; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):260-5. PubMed ID: 21609578
[TBL] [Abstract][Full Text] [Related]
7. miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1.
Yu M; Xu Y; Pan L; Feng Y; Luo K; Mu Q; Luo G
Cell Physiol Biochem; 2018; 51(4):1763-1777. PubMed ID: 30504727
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the Toll-Like Receptor/Nitric Oxide Signaling Pathway in the Pathogenesis of Cervical Cancer Caused by High-Risk Human Papillomavirus Infection.
Li J; Rao H; Jin C; Liu J
Biomed Res Int; 2017; 2017():7830262. PubMed ID: 28626766
[TBL] [Abstract][Full Text] [Related]
9. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy.
García-Zepeda SP; García-Villa E; Díaz-Chávez J; Hernández-Pando R; Gariglio P
Eur J Cancer Prev; 2013 Nov; 22(6):577-84. PubMed ID: 23603746
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
Wen X; Li D; Zhang Y; Liu S; Ghali L; Iles RK
Anticancer Drugs; 2012 Mar; 23(3):280-7. PubMed ID: 22245994
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
13. HPV16 E6 Promotes the Progression of HPV Infection-Associated Cervical Cancer by Upregulating Glucose-6-Phosphate Dehydrogenase Expression.
Chang YF; Yan GJ; Liu GC; Hong Y; Chen HL; Jiang S; Zhong Y; Xiyang YB; Hu T
Front Oncol; 2021; 11():718781. PubMed ID: 34692493
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells.
Wang H; Gao P; Zheng J
Biochem Biophys Res Commun; 2014 Sep; 451(4):556-61. PubMed ID: 25117446
[TBL] [Abstract][Full Text] [Related]
15. The molecular response of vanadium complexes of nicotinoyl hydrazone in cervical cancers--a possible interference with HPV oncogenic markers.
Nair RS; Kuriakose M; Somasundaram V; Shenoi V; Kurup MR; Srinivas P
Life Sci; 2014 Oct; 116(2):90-7. PubMed ID: 25258113
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination.
Du J; Näsman A; Carlson JW; Ramqvist T; Dalianis T
Acta Oncol; 2011 Nov; 50(8):1215-9. PubMed ID: 21726177
[TBL] [Abstract][Full Text] [Related]
17. Effects of G6PD activity inhibition on the viability, ROS generation and mechanical properties of cervical cancer cells.
Fang Z; Jiang C; Feng Y; Chen R; Lin X; Zhang Z; Han L; Chen X; Li H; Guo Y; Jiang W
Biochim Biophys Acta; 2016 Sep; 1863(9):2245-54. PubMed ID: 27217331
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.
Girón RA; Montaño LF; Escobar ML; López-Marure R
FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826
[TBL] [Abstract][Full Text] [Related]
19. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-206 suppresses proliferation and predicts poor prognosis of HR-HPV-positive cervical cancer cells by targeting G6PD.
Cui J; Pan Y; Wang J; Liu Y; Wang H; Li H
Oncol Lett; 2018 Nov; 16(5):5946-5952. PubMed ID: 30344744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
